Skip to main content
Meng Welliver, MD, Radiation Oncology, Columbus, OH, The OSUCCC - James

MengXuWelliverMDPh.D.

Radiation Oncology Columbus, OH

Hematologic Malignancies, Sarcoma, Thoracic Cancer

Associate Professor of Radiation Oncology Senior Associate Consultant

Dr. Welliver is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Welliver's full profile

Already have an account?

Summary

  • Dr. Meng Welliver is a radiation oncologist in Columbus, OH and is affiliated with Ohio State University James Cancer Hospital and Solove Research Institute as well as Ohio State University Wexner Medical Center. She received her MD, Ph.D. training from Pennsylvania State University College of Medicine, and residency training at the Hospital of University of Pennsylvania. She has been in practice for 11 years in Ohio. She specializes in hematologic malignancies, sarcoma, and thoracic cancer and is experienced in clinical investigation. She has more than 60 publications and over 500 citings.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Radiation Oncology, 2007 - 2011
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 2006 - 2007
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 2006

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2011 - 2025
  • WI State Medical License
    WI State Medical License 2024 - 2025
  • MN State Medical License
    MN State Medical License 2023 - 2024
  • MS State Medical License
    MS State Medical License 2021 - 2022
  • PA State Medical License
    PA State Medical License 2006 - 2016
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • MDM2 inhibitor AMG-232 and radiation therapy in treating patients with soft tissue sarcoma with wild-type TP53: A phase IB study (NRG-DT001). 
    2019 ASCO Annual Meeting - 6/1/2019

Hospital Affiliations